Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Coherus Biosciences (CHRS) Q3 2023 Earnings
CHRS
6
Nov
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.84
-0.65
-0.46
-0.27
Details
Expected EPS
-0.31
Actual EPS
-0.27
Surprise EPS
0.04
Surprise Percent
+12.9%
Description
Coherus Biosciences (CHRS) has reported earnings of -0.27 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login